May 10, 2024
By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE
Once again, myopia research took center stage at the Association for Research in Vision and Ophthalmology (ARVO) Meeting, held May 5–9, 2024, in Seattle, WA. The meeting featured more than 150 posters and papers on various aspects of myopia and myopia management. Here are 20 noteworthy myopia-related posters and papers:
-
- 3-year myopia control efficacy can be predicted from 1-year data https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4036500&external=true
- A Century of Myopia in the Netherlands: Unveiling the Emerging Epidemic https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4048429&external=true
- Efficacy of a next-generation design of ophthalmic lenses for myopia control: Six-month results of the CEME Study https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4045244&external=true
- Predictive factors associated with incident myopia in childhood. https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4047734&external=true
- Dietary Omega-3 Polyunsaturated Fatty Acids as a Protective Factor of Myopia: Hong Kong Children Eye Study. https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4045255&external=true
- A Randomized Controlled Trial for Myopia Progression Control Using Catenary Power Profile Contact Lenses: 12-month Effectiveness and Safety. https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4049857&external=true
- Assessing the 2-year Efficacy of Atropine, Orthokeratology, and Combined Therapies: Myopia Control and Choroidal change – Insights from an Age-stratified Randomized Controlled Trial https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4043459&external=true
- Biometrically defining myopia with the Refractive Mechanism Map: Relationship with myopia progression and treatment efficacy. https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4048987&external=true
- Control of Myopia Using Diffusion Optics Technology (DOT) Spectacle Lenses in a Chinese population. https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4048229&external=true
- Defocus Incorporated Multiple Segment lenses and 0.025% atropine for myopia control in a European population: 12-month results of a randomized clinical trial https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4045828&external=true
- Do past axial elongation and myopia progression predict the future? Results from the BLINK Study https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4049687&external=true
- Five-Year Clinical Trial of Low-concentration Atropine for Myopia Progression (LAMP) Study: Phase 4 Report. https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4048205&external=true
- Highly Aspherical Lenslet Target (HALT) technology in combination with low-dose atropine to control myopia progression https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4049211&external=true
- Incidence and progression of myopia in young adults. https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4050576&external=true
- Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004—A reappraisal and model https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4027817&external=true
- Influence of first-time correction on myopia progression and axial elongation in myopic children wearing spectacle lenses with and without aspherical lenslets https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4049944&external=true
- The myopia control effect in children wearing orthokeratology lenses with different back optical zone diameters https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4027873&external=true
- Myopia control efficacy through Emmetropic Progression Ratio:1-year of spectacle wear with cylindrical annular refractive elements (CARE). https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4035816&external=true
- The short-term effects of spectacle-based myopia management interventions on dynamic vision. https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4045535&external=true
- Projection of Glaucoma Burden Worldwide in 2060 with Myopia Surge https://eppro02.ativ.me/web/page.php?nav=false&page=IntHtml&project=ARVO24&id=4050544&external=true
